Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?

被引:34
作者
Cerveny, KC [1 ]
Sawitzke, AD [1 ]
机构
[1] Univ Utah, Div Rheumatol, Salt Lake City, UT 84132 USA
关键词
antiphospholipid antibody syndrome; catastrophic antiphospholipid antibody syndrome; thrombotic thrombocytopenic purpura;
D O I
10.1177/096120339900800613
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The catastrophic antiphospholipid antibody syndrome (CAPS) is an uncommon disorder characterized by widespread micro- and macrovascular changes due to intravascular thrombosis. This complication of the antiphospholipid antibody syndrome is often fatal and recurrences are very rare. The differential diagnosis of CAPS includes thrombotic thrombocytopenic purpura (TTP) and this distinction may be difficult, but essential, for appropriate therapy. Plasmapheresis is effective in both conditions, but anticoagulation, a mainstay in the treatment of CAPS, could be disastrous in TTP. We present the case of an elderly woman who survived two episodes of CAPS four years apart and whose clinical findings were also suggestive of TTP. The characteristics of TTP and CAPS are compared and the importance of accurate diagnosis is emphasized.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 50 条
  • [1] Chronic relapsing thrombotic thrombocytopenic purpura and antiphospholipid antibodies: A report of two cases
    Trent, K
    Neustater, BR
    Lottenberg, R
    AMERICAN JOURNAL OF HEMATOLOGY, 1997, 54 (02) : 155 - 159
  • [2] A rare combination of thrombotic thrombocytopenic purpura and antiphospholipid syndrome
    Viner, Maya
    Murakhovskaya, Irina
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (05) : 411 - 415
  • [3] Presumed antiphospholipid syndrome and thrombotic thrombocytopenic purpura: An infrequent association
    Dolin, Hattie Hanna
    Dziuba, Mark
    Pappada, Scott M.
    Papadimos, Thomas John
    CLINICAL CASE REPORTS, 2019, 7 (10): : 1984 - 1988
  • [4] Caplacizumab for relapsing thrombotic thrombocytopenic purpura
    Kaczmarek, Veronika
    Holle, Johannes
    Astudillo, Rebekka
    Kempf, Caroline
    Baler, Philip
    Mueller, Dominik
    PEDIATRIC NEPHROLOGY, 2019, 34 (09) : 1625 - 1628
  • [5] Caplacizumab for relapsing thrombotic thrombocytopenic purpura
    Veronika Kaczmarek
    Johannes Holle
    Rebekka Astudillo
    Caroline Kempf
    Philip Bufler
    Dominik Müller
    Pediatric Nephrology, 2019, 34 : 1625 - 1628
  • [6] Primary antiphospholipid syndrome with thrombotic thrombocytopenic purpura: a very unusual association
    Carvalho, J. F.
    Freitas, C. A. E. W.
    Lima, I. V. S.
    Leite, C. C.
    Lage, L. V.
    LUPUS, 2009, 18 (09) : 841 - 844
  • [7] Management of immune thrombocytopenic purpura associated with the antiphospholipid antibody syndrome
    Leuzzi, RA
    Davis, GH
    Cowchock, FS
    Murphy, S
    Vernick, JJ
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (02) : 197 - 200
  • [8] THE ROLE OF SPLENECTOMY IN THE TREATMENT OF RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA
    VELTMAN, GAM
    BRAND, A
    LEEKSMA, OC
    TENBOSCH, GJA
    VANKRIEKEN, JHJM
    BRIET, E
    ANNALS OF HEMATOLOGY, 1995, 70 (05) : 231 - 236
  • [9] Splenectomy in patients with refractory or relapsing thrombotic thrombocytopenic purpura
    de la Rubia, J
    García, I
    Jarque, I
    Arriaga, F
    Gomis, F
    Sanz, MA
    HAEMATOLOGICA, 2000, 85 (04) : 440 - 441
  • [10] Relapsing thrombotic thrombocytopenic purpura in association with recurrent pancreatitis
    Daryanani, S
    Wilde, JT
    CLINICAL AND LABORATORY HAEMATOLOGY, 1998, 20 (05): : 317 - 318